Skip to Content

Clinical Trial Details

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Br Ca. e3 Breast Cancer Study- evaluating everolimus with endocrine therapy


This randomized phase III trial studies how well giving hormone therapy together with or without everolimus work in treating patients with breast cancer. Read More >>

IRB Protocol Number
SWOG S1207

Clinical Trial Categories

  • Breast Cancer
Barbara Beauchemin, RN, BSN at 603-224-2556